 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
ARB, the native token of Arbitrum (a leading Ethereum Layer 2 solution), is currently trading at $0.39. Reaching $2 by year-end would require a 5x surge
ARB, the native token of Arbitrum (a leading Ethereum Layer 2 solution), is currently trading at $0.39. Reaching $2 by year-end would require a 5x surge. Here's what needs to happen:
Key Drivers for a $2 ARB
- Ethereum Bull Run: If ETH rallies significantly, perhaps due to ETF inflows or a broader market uptrend, ARB could benefit as a top Layer 2 token.
- Adoption Growth:
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research！
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
-
- Robinhood Chain Sees Surge in Perps as Spot Trading Cools Amidst Broader Market Shifts
- Sep 29, 2026 at 12:05 pm
- Robinhood Chain's trading landscape is bifurcating: perpetual futures volume is skyrocketing, while spot trading is cooling. This trend hints at a strategic shift in trader behavior on the platform.
-
